Masters JC, Jermain B, Liu A, Cesari R, et al. Population Pharmacokinetics and Exposure-Response of Sasanlimab, a Checkpoint Inhibitor, in Patients with Non-Muscle Invasive Bladder Cancer and Other Solid Tumors. J Clin Pharmacol 2026;66:e70295.
PMID: 42742477